ResMed | RMD - 流动资产

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 32.61B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	流动资产	更改		日
Ansell	USD 1.11B		5.2M	2025-12
Artivion	USD 371.38M		13.86M	2026-06
AtriCure	USD 345.53M		31.84M	2026-06
Baxter International	USD 6.99B		142M	2026-06
Cochlear	AUD 1.37B		43.9M	2025-12
Cooper Companies	USD 2.3B		166M	2026-03
CSL	USD 11.85B		1000K	2025-12
Dexcom	USD 4.09B		245.1M	2026-06
Edwards Lifesciences	USD 6.82B		590.2M	2026-06
Fisher Paykel Healthcare	NZD 1.15B		168.5M	2026-06
Globus Medical	USD 2.22B		17.39M	2026-06
Haemonetics	USD 810.83M		24.05M	2026-06
Idexx Laboratories	USD 1.51B		55.41M	2026-06
Inogen	USD 203.72M		594K	2025-09
Insulet	USD 1.85B		139.6M	2026-06
Integra LifeSciences	USD 1.19B		19.46M	2026-06
Intuitive Surgical	USD 12.33B		807.5M	2026-06
Medtronic	USD 24.07B		75M	2025-12
Philips	EUR 9.33B		454M	2026-06
Ramsay Health Care	AUD 3.56B		480.3M	2025-12
ResMed	USD 4.32B		260.68M	2026-06
Sigma Healthcare	AUD 2.91B		2B	2025-12
Sonic Healthcare	AUD 2.3B		52.76M	2024-12
Steris	USD 2.45B		51.2M	2026-06
Teleflex	USD 1.88B		16.21M	2026-06
Thermo Fisher Scientific	USD 23.36B		1.05B	2026-06